Professional Documents
Culture Documents
Nephrology
Lectures
Kidneys
• Kidney-shaped retroperitoneal organs
• 12 cm long
Kidney Function
Nephrons
• The functional and
structural unit of kidney
• Glomerulus = filtration
• Renal tubule =
excretion, reabsorption,
secretion
• About 1 million
nephrons per kidney
Nephrons
50 – 60% → prerenal
30 – 40% → intrinsic renal (90% is ischemic ATN)
5% → postrenal
Prerenal azotemia
1. Hypovolemia
– Hemorrhage
– GI loss - ↓ intake, vomiting, diarrhea, GI bleeding
– Renal loss – polyuria – diuretics, osmotic diuresis
– Insensible loss – skin, respiratory – sweat
– Third space loss – burn, crush injury, acute pancreatitis, intestinal
obstruction
2. Hypotension – different types of shock
3. Decreased effective circulating volume – edematous states
– CHF
– Hepatic failure: hepatorenal syndrome
– Nephrotic syndrome
4. Selective renal ischemia – Impaired renal autoregulation
– NSAIDs: block prostaglandin-mediated afferent arteriolar relaxation
– ACE-I/ARB: block angiotensin II mediated efferent arteriolar vasoconstriction
– Cyclosporine
Intrinsic AKI
• Glomerular – Microvascular causes
– AGN
– Malignant hypertension
– Vasculitis, Collagen vascular diseases – SLE, scleroderma renal crisis
– thrombotic microangiopathies: TTP-HUS, DIC; preeclampsia; antiphospholipid
antibody syndrome, radiation nephritis, malignant nephrosclerosis,
• Tubular - ATN
– Ischemic – severe prerenal causes
– Nephrotoxic:
• Exogenous: AG, AmphB, tenofovir, cisplastin, contrast nephropathy (iodinated contrasts)
• Endogenous: hemolysis, rhabdomyolysis, myeloma, intratubular crystals, TLS
• Tubulointerstitial – interstitial nephritis
– Infectious/sepsis, inflammatory, infiltrative, allergic
• Renovascular – Large vessel diseases
– ATH, thrombosis, thromboembolism, renal artery dissection
– renal vein compression e.g abdominal compartment syndrome: elevated
intraabdominal pressures >20 mmHg
Postrenal AKI
BOO
Clinical features
• Hemorrhage, vomiting, diarrhea, polyuria
• prostatic disease, nephrolithiasis, or pelvic or
paraaortic malignancy
• Medications: diuretics, NSAIDs, ACE inhibitors,
and ARBs
• Complications of AKI
• Signs of dehydration/hypovolemia
– Orthostatic hypotension, tachycardia, reduced JVP
– Decreased skin turgor, and dry mucous membranes
Clinical features
• Oliguria/Anuria
• Fatigue
• Peripheral edema, pulmonary edema, pleural
effusion or ascites, Pericardial effusion
• Decreased appetite, nausea and vomiting
• Hiccups
• Mucocutaneous bleeding
• Change in mental status/flapping tremor/seizure
Work up
• Urinalysis
• BUN and creatinine
• Serum electrolytes
• ECG – to look for evidence of hyperkalemia
• Renal ultrasound to exclude urinary tract
obstruction and assess kidney size
• Renal biopsy-when glomerulonephritis is
suspected, cause is not clear
• Other investigation should be done based on the
suspected specific etiologies
AKI complications
1. Acute renal failure – Uremia
2. Hypervolemia, hypovolemia
3. Serum electrolyte and acid base disturbance
a. Hyponatremia
b. Hyperkalemia
c. Hyperphosphatemia
d. Hypocalcemia
e. Metabolic acidosis
4. Cardiac – arrhythmia, pericarditis, pericardial effusion
5. Hematologic – anemia, bleeding
6. Infections – the commonest cause of death in AKI
7. Malnutrition
AKI – management principles
• Treat correctable causes
1. Prerenal → hydration
2. Postrenal → relieve obstruction
3. Intrinsic → etiologic specific e.g DC nephrotoxic drugs or dose
adjustment
• Supportive care: symptomatic Rx, Treat & prevent complications
1. ABCs with monitoring (VS, fluid balance, cardiac monitor, serial sCr)
2. Volume management – fluid restriction, diuretics
3. Correct electrolyte and acid derangements – hyperkalemia
4. Correct anemia; treat CHF, hypertensive crisis
5. Antibiotics
6. GI prophylaxis, DVT prophylaxis
7. Nutritional support
• Renal replacement therapy (RRT) – dialysis
AKI Rx – general issues
1. Optimization of systemic and renal
hemodynamics through volume resuscitation
and judicious use of vasopressors
2. Elimination of nephrotoxic agents (e.g., ACE
inhibitors, ARBs, NSAIDs, aminoglycosides) if
possible
3. Initiation of renal replacement therapy when
indicated
AKI Rx – specific issues
Renal replacement therapy
• Dialysis
• Kidney transplantation
CKD
CKD definition
A kidney damage for ≥3 months as defined by
1. GFR ≤60 mL/min/1.73m2
2. Abnormal blood or urine tests
3. Abnormal pathologic findings
4. Abnormal imaging sturdies
Pathophysiology of CKD
• Kidney injury → destruction of nephrons →
↓renal function & GFR
• Adaptation causes ↑nephron size &
↑glomerular pressure
• ↑glom pressure causes further loss of
nephrons
Progressive dysfunction
CKD causes
• Prerenal causes
– Hypertensive nephrosclerosis
– Renal aa stenosis
• Renal cause
– Glomerular = chronic GN of any cause
– Tubulointerstitial nephropathy
• Post-renal cause
– Obstructive uropathy
CKD causes
1. Diabetic nephropathy
2. Hypertension-associated CKD (hypertensive
nephropathy + vascular and ischemic kidney
disease)
3. Chronic Glomerulonephritis
4. Tubulointerstitial nephropathy
5. Cystic kidney diseases – ADPKD
6. Congenital kidney diseases – CAKUT
CKD staging
Clinical features
• Volume overload
• Hypertension
• Electrolyte disturbance
• Acid-base disturbance
• Uremia
• Anemia
• Bone-mineral disorders
• Cardiovascular disease
Uremia
• A clinical syndrome accompanying renal
failure
• Due to accumulation of urea (azotemia) and
other toxic waste products
Uremia
1. Renal excretory dysfunction → accumulation
of toxins including products of protein
metabolism
2. Metabolic and endocrine failure
3. Progressive systemic inflammation →
vascular and nutritional consequences
Uremia features
Work up
• CBC, RBC indices
• Urinalysis
• BUN, Creatinine and estimated GFR
• Electrolytes
• Calcium, Phosphate, PTH, ALP, DEXA
• Fasting blood glucose, Fasting lipids
• Renal imaging
CKD management
• Dietary modification
• Rx reversible causes
– Avoid nephrotoxic drugs
• Prevent or slow progression
– ACE inhibitors, ARBs
• Rx comorbidities
– Glycemic control, BP control ≤130/80 mmHg, Statins
– Quit smoking/alcohol
• Rx complications
• RRT
ሜልክዮር MD
CKD management
ሜልክዮር MD
Dietary modification
• Nutritional support – adequate calorie
• Calcium supplement
• Salt and water restriction
– 2 – 3 L/d, sodium individualized
• Potassium restriction <60meq/day
• ?Protein restriction <1g/kg
– Slows progression of disease
• Phosphorus restriction <1g/d
ሜልክዮር MD
Dialysis
• ESRD with eGFR <15 ml/min
• Refractory hyperkalemia
• Refractory fluid overload
• Refractory metabolic acidosis
• Uremic encephalopathy, pericarditis, gastritis